Skip to content

FP7H2020HORIZON

Sanofi-Aventis Recherche & Developpement

Country
FRFrance
Defence projects
0
Projects, all programmes
70
As coordinator
1
EU contribution (CORDIS)
EUR 2,618,473
Active
2009 to 2026

Projects

70 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
PINPOINT-NMRPinpoint-NMR: A sequence-specific labeling technique to accelerate NMR investigation of large proteinsHORIZON2026Associated partnerEUR 0
READIResearch in Europe and Diversity InclusionHORIZON2025ParticipantEUR 0
PROCRYSTALCrystallisation towards efficient and sustainable biomanufacturingHORIZON2025Associated partnerEUR 0
GRASSHOPPERThe GRASSHOPPER network: Jumping forward from preclinical development of pediatric cancer drugs to clinical implementationHORIZON2024Associated partnerEUR 0
DeMythif.AIPhD excellence program in Paris-Saclay to unravel AI uncertaintyHORIZON2024Associated partnerEUR 0
AD-RIDDLEREAL-WORLD IMPLEMENTATION, DEPLOYMENT AND VALIDATION OF EARLY DETECTION TOOLS AND LIFESTYLE ENHANCEMENTHORIZON2024ParticipantEUR 0
NHPigReducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig ModelsHORIZON2024ParticipantEUR 0
MathPhDInFranceInternational Doctoral Training in Mathematical Sciences in FranceHORIZON2023Associated partnerEUR 0
EDENT1FIEuropean action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease InterceptionHORIZON2023Associated partnerEUR 0
SMiPAX4Signalling of Minor Pocket Agonists at CXCR4HORIZON2022Associated partnerEUR 0
EPNDEuropean platform for neurodegenerative disordersH20202021ParticipantEUR 0
H2OH2O Health Outcomes ObservatoryH20202020ParticipantEUR 0
PREMIERPrioritisation and Risk Evaluation of Medicines in the EnviRonmentH20202020ParticipantEUR 0
EU-PEARLEU Patient- cEntric clinicAl tRial pLatformH20202019ParticipantEUR 0
MOBILISE-DConnecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsementH20202019ParticipantEUR 0
NeuroDeRiskNeurotoxicity De-Risking in Preclinical Drug DiscoveryH20202019ParticipantEUR 0
NEURONETEfficiently Networking European Neurodegeneration ResearchH20202019ParticipantEUR 0
CARDIATEAMCARdiomyopathy in type 2 DIAbetes mellitusH20202019ParticipantEUR 0
Trials@HomeTrials@Home: Center of Excellence – Remote Decentralised Clinical TrialsH20202019ParticipantEUR 0
imSAVARImmune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapiesH20202019ParticipantEUR 0

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.